208 related articles for article (PubMed ID: 25903443)
21. Functionalized gold nanoparticles for topical delivery of methotrexate for the possible treatment of psoriasis.
Bessar H; Venditti I; Benassi L; Vaschieri C; Azzoni P; Pellacani G; Magnoni C; Botti E; Casagrande V; Federici M; Costanzo A; Fontana L; Testa G; Mostafa FF; Ibrahim SA; Russo MV; Fratoddi I
Colloids Surf B Biointerfaces; 2016 May; 141():141-147. PubMed ID: 26852097
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of fixed low-dose isotretinoin (20 mg, alternate days) with topical clindamycin gel in moderately severe acne vulgaris.
Sardana K; Garg VK; Sehgal VN; Mahajan S; Bhushan P
J Eur Acad Dermatol Venereol; 2009 May; 23(5):556-60. PubMed ID: 19143903
[TBL] [Abstract][Full Text] [Related]
23. Nano-lipoidal carriers of isotretinoin with anti-aging potential: formulation, characterization and biochemical evaluation.
Raza K; Singh B; Singla N; Negi P; Singal P; Katare OP
J Drug Target; 2013 May; 21(5):435-42. PubMed ID: 23336181
[TBL] [Abstract][Full Text] [Related]
24. Effect of DC/mDC iontophoresis and terpenes on transdermal permeation of methotrexate: in vitro study.
Prasad R; Koul V; Anand S; Khar RK
Int J Pharm; 2007 Mar; 333(1-2):70-8. PubMed ID: 17116378
[TBL] [Abstract][Full Text] [Related]
25. Topical delivery of lycopene using microemulsions: enhanced skin penetration and tissue antioxidant activity.
Lopes LB; VanDeWall H; Li HT; Venugopal V; Li HK; Naydin S; Hosmer J; Levendusky M; Zheng H; Bentley MV; Levin R; Hass MA
J Pharm Sci; 2010 Mar; 99(3):1346-57. PubMed ID: 19798758
[TBL] [Abstract][Full Text] [Related]
26. Interactions of hyaluronic Acid with the skin and implications for the dermal delivery of biomacromolecules.
Witting M; Boreham A; Brodwolf R; Vávrová K; Alexiev U; Friess W; Hedtrich S
Mol Pharm; 2015 May; 12(5):1391-401. PubMed ID: 25871518
[TBL] [Abstract][Full Text] [Related]
27. Analysis of clinical efficacy, side effects, and laboratory changes among patients with acne vulgaris receiving single versus twice daily dose of oral isotretinoin.
Ahmad HM
Dermatol Ther; 2015; 28(3):151-7. PubMed ID: 25754162
[TBL] [Abstract][Full Text] [Related]
28. Topical drug delivery by a polymeric nanosphere gel: Formulation optimization and in vitro and in vivo skin distribution studies.
Batheja P; Sheihet L; Kohn J; Singer AJ; Michniak-Kohn B
J Control Release; 2011 Jan; 149(2):159-67. PubMed ID: 20950659
[TBL] [Abstract][Full Text] [Related]
29. Dermal peptide delivery using enhancer moleculs and colloidal carrier systems. Part II: Tetrapeptide PKEK.
Neubert RHH; Sommer E; Schölzel M; Tuchscherer B; Mrestani Y; Wohlrab J
Eur J Pharm Biopharm; 2018 Mar; 124():28-33. PubMed ID: 29247690
[TBL] [Abstract][Full Text] [Related]
30. Nanotechnological Carriers for Treatment of Acne.
Verma S; Utreja P; Kumar L
Recent Pat Antiinfect Drug Discov; 2018; 13(2):105-126. PubMed ID: 30227825
[TBL] [Abstract][Full Text] [Related]
31. ARTICLE: Advances in Oral Isotretinoin Therapy.
Jones M; Armstrong AW; Baldwin H; Stein Gold L; Kircik LH
J Drugs Dermatol; 2021 May; 20(5):s5-s11. PubMed ID: 33938693
[TBL] [Abstract][Full Text] [Related]
32. Microemulsions mediated effective delivery of methotrexate hydrogel: more than a tour de force in psoriasis therapeutics.
Amarji B; Garg NK; Singh B; Katare OP
J Drug Target; 2016; 24(2):147-60. PubMed ID: 26204326
[TBL] [Abstract][Full Text] [Related]
33. Isotretinoin-Delonix polymeric nanoparticles: Potentials for skin follicular targeting in acne treatment.
Ogunjimi AT; Chahud F; Lopez RFV
Int J Pharm; 2021 Dec; 610():121217. PubMed ID: 34688848
[TBL] [Abstract][Full Text] [Related]
34. ABSORICA (isotretinoin): a new form.
Scheinfeld N
Skinmed; 2013; 11(2):117-9. PubMed ID: 23745231
[No Abstract] [Full Text] [Related]
35. Novel drug delivery systems: potential in improving topical delivery of antiacne agents.
Date AA; Naik B; Nagarsenker MS
Skin Pharmacol Physiol; 2006; 19(1):2-16. PubMed ID: 16247244
[TBL] [Abstract][Full Text] [Related]
36. Comparison of combined azelaic acid cream plus oral minocycline with oral isotretinoin in severe acne.
Gollnick HP; Graupe K; Zaumseil RP
Eur J Dermatol; 2001; 11(6):538-44. PubMed ID: 11701404
[TBL] [Abstract][Full Text] [Related]
37. A dietary supplement to reduce side effects of oral isotretinoin therapy in acne patients.
Fabbrocini G; Cameli N; Lorenzi S; De Padova MP; Marasca C; Izzo R; Monfrecola G
G Ital Dermatol Venereol; 2014 Aug; 149(4):441-5. PubMed ID: 25068233
[TBL] [Abstract][Full Text] [Related]
38. Uptake of microemulsion components into the stratum corneum and their molecular effects on skin barrier function.
Hathout RM; Mansour S; Mortada ND; Geneidi AS; Guy RH
Mol Pharm; 2010 Aug; 7(4):1266-73. PubMed ID: 20545350
[TBL] [Abstract][Full Text] [Related]
39. Isotretinoin treatment induces oxidative toxicity in blood of patients with acne vulgaris: a clinical pilot study.
Erturan İ; Naziroğlu M; Akkaya VB
Cell Biochem Funct; 2012 Oct; 30(7):552-7. PubMed ID: 22517509
[TBL] [Abstract][Full Text] [Related]
40. Development and Evaluation of Topical Delivery of Microemulsions Containing Adapalene (MEs-Ap) for Acne.
Shao B; Sun L; Xu N; Gu H; Ji H; Wu L
AAPS PharmSciTech; 2021 Apr; 22(3):125. PubMed ID: 33825087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
